mylan mylan
Stories About

mylan

An FDA inspection of this Ranbaxy facility in Toansa, Punjab, India, in 2014, revealed drug quality testing violations, resulting in the FDA prohibiting Ranbaxy from marketing drugs in the U.S. that were manufactured at this plant. Dhiraj Singh/Getty Images hide caption

toggle caption
Dhiraj Singh/Getty Images

Heather Bresch, CEO of Mylan Pharmacueticals, will face lawmakers' questions Wednesday about the company's steep price hikes for the company's life-saving EpiPen auto-injector. Dale Sparks/AP hide caption

toggle caption
Dale Sparks/AP

Mylan CEO Claims EpiPens Aren't As Profitable As Everyone Thinks

  • Download
  • <iframe src="https://www.npr.org/player/embed/494879607/494914776" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript